A sweeping new survey of nearly 10,000 individuals across 45 European countries has uncovered a severe mental health crisis within the rare disease community. Patients and caregivers report depression and anxiety rates seven times higher than the general EU population. Loneliness is up to 20 times more common, while suicidal thoughts are 10 times more prevalent.
Jessie Dubief, Social Research Director at EURORDIS, states these findings expose a chronic emergency rather than temporary distress. Anxiety levels now mirror those observed in the general population during the height of the COVID-19 pandemic. This represents a daily reality for millions across the continent.
Despite the urgent need, a significant treatment gap persists. Nearly three-quarters of respondents required professional psychological support in the past six months, yet only half received it. Barriers include prohibitive costs, extensive waiting lists, geographic distance, and insufficient information on available services.
EURORDIS Chief Jean Saslawsky emphasizes that rare disease care must be mental health-informed at every stage. He calls on healthcare systems to proactively recognize these challenges and streamline access to essential psychological support for this vulnerable demographic.